Latest News about REGN
Recent news which mentions REGN
2 Big Stock Bets That Are Insiders Are Buying Now
December 06, 2021
From InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For December 6, 2021
December 06, 2021
From Benzinga
The Week Ahead In Biotech (Dec. 6-Dec. 11): Daré FDA Decision, Adcom Tryst For Reata, Multiple Conference Presentations And More
December 06, 2021
From Benzinga
Regeneron: Surfing on Covid, With More Under the Surface
December 02, 2021
From InvestorPlace
Why Are Stocks Down Today? 4 Things to Know.
November 30, 2021
From InvestorPlace
HC Wainwright Sees 'Buying Opportunity' For This COVID-19 Antibody Stock After Sell-Off
November 30, 2021
Tickers
REGN
From Benzinga
7 Drug Stocks to Buy Now While They’re Still on Sale
November 30, 2021
From InvestorPlace
From MarketWatch
WHO urges calm approach to omicron variant of COVID, warns travel restrictions may undermine surveillance and tracking
November 30, 2021
From MarketWatch
Retail Stocks Trading Lower on Weaker Black Friday Numbers
November 30, 2021
From Benzinga
The Daily Biotech Pulse: Cumberland Jumps On FDA Nod, Regeneron Says Antibody Treatment May Be Less Effective Against Omicron, ImmunoGen Readout
November 30, 2021
From Benzinga
JPMorgan’s S&P 500 forecast for 2022 is among the most bullish on Wall Street. Here’s the biggest risk it sees for stocks.
November 30, 2021
From MarketWatch
ADGI Stock Soars as Analysts Lock On to Its Omicron-Fighting Potential
November 29, 2021
From InvestorPlace
From Benzinga
Merck stock dives after Citi downgrades on ‘high probability’ that HIV treatment will be abandoned
November 29, 2021
From MarketWatch
Regeneron Extends Hearing Loss Gene Therapy pact With Decibel
November 22, 2021
From Benzinga
From Motley Fool
Is Merck Stock a Buy?
November 20, 2021
From Motley Fool
Why Connect Biopharma Stock Is Crashing Today
November 19, 2021
From Motley Fool
The Daily Biotech Pulse: Connect Biopharma Sinks On Eczema Drug Readout, Enanta Pulls Plug On HBV Drug, Clinical Setback For Merck In HIV Trial
November 19, 2021
From Benzinga
From Motley Fool
From Benzinga
5 Stocks To Watch For November 15, 2021
November 15, 2021
From Benzinga
Europe Approves Regeneron - Roche's COVID-19 Antibody Cocktail
November 12, 2021
From Benzinga
EU Regulator Backs Regeneron-Roche's COVID-19 Drug
November 11, 2021
From Benzinga
Better COVID Stock: Merck vs. Pfizer
November 09, 2021
From Motley Fool
From Benzinga
U.S. reopens to vaccinated travelers from 33 countries after 18 months, as global tally of COVID-19 cases tops 250 million
November 08, 2021
Tickers
REGN
Tags
REGN
From MarketWatch
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
